Bayer Pharma AG et al v. Aurobindo Pharma Limited et al
Bayer Pharma AG, Bayer AG and Janssen Pharmaceuticals, Inc. |
Aurobindo Pharma Limited and Aurobindo Pharma USA, Inc. |
1:2023cv01372 |
December 1, 2023 |
US District Court for the District of Delaware |
Richard G Andrews |
Patent - Abbreviated New Drug Application(ANDA) |
35 U.S.C. § 271 Patent Infringement |
None |
Docket Report
This docket was last retrieved on January 26, 2024. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 13 STIPULATION for Extension of Time to Answer, Move or Otherwise Respond to Complaint to February 9, 2024 - filed by Aurobindo Pharma Limited, Aurobindo Pharma USA Inc.. (Myer, R.) Modified on 1/26/2024 (nms). |
SO ORDERED, re (D.I. 212 in 21-md-3017-RGA-LDH; D.I. 13 in 23-cv-1372-RGA) STIPULATION for Extension of Time to Answer, Move or Otherwise Respond to Complaint to February 9, 2024. Signed by Judge Richard G. Andrews on 1/26/2024. Associated Cases: 1:21-md-03017-RGA-LDH, 1:23-cv-01372-RGA(nms) |
Reset Answer Deadlines: Aurobindo Pharma Limited answer due 2/9/2024; Aurobindo Pharma USA, Inc. answer due 2/9/2024. (nms) |
SO ORDERED, re #12 STIPULATION for Extension of Time (*Reset Answer Deadlines: Aurobindo Pharma Limited answer due 1/26/2024; Aurobindo Pharma USA, Inc. answer due 1/26/2024). Signed by Judge Richard G. Andrews on 12/29/2023. (nms) |
Filing 12 STIPULATION for Extension of Time to answer, move or otherwise respond to Complaint to January 26, 2024 - filed by Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc.. (Myer, R.) Modified on 12/28/2023 (nms). |
Filing 11 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Aurobindo Pharma Limited for Aurobindo Pharma USA, Inc. filed by Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc.. (Myer, R.) |
Filing 10 NOTICE of Appearance by R. Touhey Myer on behalf of Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc. (Myer, R.) |
Filing 9 AFFIDAVIT of Service for Summons, Complaint and related papers served on Aurobindo Pharma Limited on December 8, 2023, filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) |
Filing 8 SUMMONS Returned Executed by Bayer Pharma AG, Janssen Pharmaceuticals, Inc., Bayer AG.Aurobindo Pharma USA, Inc. served on 12/8/2023, answer due 12/29/2023. (Fahnestock, Derek) |
Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) |
Filing 7 Summons Issued as to Aurobindo Pharma Limited on 12/1/2023; Aurobindo Pharma USA, Inc. on 12/1/2023. (Attachments: #1 Summons Issued)(mkr) |
Filing 6 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Johnson & Johnson for Janssen Pharmaceuticals, Inc. filed by Janssen Pharmaceuticals, Inc. (mkr) |
Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Bayer AG for Bayer Pharma AG filed by Bayer AG and Bayer Pharma AG. (mkr) |
Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,828,310 B2. (mkr) |
Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: No earlier than October 17, 2023. Date of Expiration of Patent: January 31, 2039.Thirty Month Stay Deadline: No earlier than April 17. 2026. (mkr) |
Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mkr) |
Filing 1 COMPLAINT filed against Aurobindo Pharma Limited, and Aurobindo Pharma USA, Inc. (Filing fee $ 405, receipt number ADEDC-4284983.) - filed by Bayer Pharma AG, Janssen Pharmaceuticals, Inc., and Bayer AG. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet)(mkr) |
Remark: MDL panel has been advised. (mkr) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.